|
Judy A. Hemberger, Ph.D., is the former co-founder, executive vice president and chief operating officer of Pharmion Corporation and has recently served as interim chief executive officer of Zosano Pharma, a privately-held biotechnology company. Prior to her positions at Pharmion from 1999 to 2006, she worked at Marion Laboratories and successor companies Marion Merrell Dow and Hoechst Marion Roussel. She led a number of strategic functions including Professional Education, Global Regulatory Affairs, Global Medical Affairs, and Commercial Development. Her final role in the company was senior vice president of Global Drug Regulatory Affairs. Dr. Hemberger currently serves on the Board of Directors of Renovis, Zymogenetics, Zosano Pharma, Atani, Ltd., Chroma Therapeutics and Perrigo Company. Dr. Hemberger received her Bachelor of Science degree in Biology and Chemistry from Mount St. Scholastica College and completed her doctorate degree in Pharmacology from the University of Missouri. Dr. Hemberger also earned an MBA in Business from Rockhurst College. | 